2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual

Partnering Events:

TechConnect Summit
Clean Technology 2008

MGP Biotechnologies, LLC

R. Acey
MGP Biotechnologies, LLC, US

pharmaceuticals, biotech

MGP is an early stage biotechnology company organized as an LLC. Our mission is to develop innovative products, methodologies, and intellectual property to unique and commercially valuable opportunities relevant to human health. Our patented technology is based on a novel metal binding protein (MT) that has a wide range of applications. These include removal of mercury based preservatives from vaccines, chelation therapy, agents for the treatment of autoimmune diseases, detection and treatment of tumors, water remediation (potable and industrial), environmental cleanup (civilian and military), and recovery of precious metals. Our initial target market is to develop a point-of-use syringe filter for removal of the mercury based preservative thimerosal from flu vaccine.

Nanotech 2008 Conference Program Abstract